VioQuest Pharmaceuticals (VOQP) Stock Price, News & Analysis

Company Overview

VioQuest Pharmaceuticals, Inc. (OTCMKTS:VOQP) is a development-stage biopharmaceutical company that specializes in the formulation and commercialization of prescription topical products for dermatological and related conditions. The company applies proprietary drug‐delivery technologies and synthetic bioactive compounds to create treatments aimed at reducing inflammation, itching and abnormal skin cell proliferation.

VioQuest’s research and development pipeline centers on investigational topical therapies for conditions such as eczema, psoriasis and rosacea. Working with contract research organizations and clinical partners, the company advances its lead candidates through preclinical studies and early‐stage clinical trials to assess safety, efficacy and tolerability. Its product platform emphasizes biocompatible carriers and novel compound analogs to improve therapeutic performance.

Headquartered in the United States, VioQuest collaborates with dermatology clinics, academic medical centers and specialty contract manufacturers to support its development programs. The management team draws on industry experience in pharmaceutical development, regulatory strategy and commercial operations as the company pursues regulatory clearances and strategic partnerships.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Today: 8/22/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:VOQP
• CIK: N/A
• Web: www.vioquestpharm.com
• Phone: (612) 220-3237
• Fax: N/A
• Employees: 3
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A